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Abstract: A (model) composite system for drug delivery was developed based on a thermoresponsive
hydrogel loaded with microparticles. We used Pluronic F127 hydrogel as the continuous phase
and alginate microparticles as the dispersed phase of this composite system. It is well known that
Pluronic F127 forms a gel when added to water in an appropriate concentration and in a certain
temperature range. Pluronic F127 hydrogel may be loaded with drug and injected, in its sol state,
to act as a drug delivery system in physiological environment. A rheological characterization
allowed the most appropriate concentration of Pluronic F127 (15.5 wt%) and appropriate alginate
microparticles contents (5 and 10 wt%) to be determined. Methylene blue (MB) was used as model
drug to perform drug release studies in MB loaded Pluronic hydrogel and in MB loaded alginate
microparticles/Pluronic hydrogel composite system. The latter showed a significantly slower MB
release than the former (10 times), suggesting its potential in the development of dual cargo release
systems either for drug delivery or tissue engineering.
Keywords: Pluronic/water systems; alginate microparticles; composites; injectable gels; rheology;
dual cargo delivery systems
1. Introduction
Hydrogels consist of three-dimensional crosslinked hydrophilic polymeric networks that absorb
and retain large amounts of water or biological fluids while maintaining the structure; they have
several unique characteristic features, which include resemblance to tissues’ extra cellular matrix
(ECM), support of cell proliferation and migration, controlled release of growth factors, cell and drugs,
minimal mechanical irritation to surrounding tissue [1,2].
Hydrogels have been used extensively in the development of smart drug delivery systems.
One method of hydrogel preparation is the covalent crosslinking of a precursor solution [3].
Alternatively, physical hydrogels can form when a specific stimulus, like temperature, is applied, or in
the presence of ions [4,5].
Thermally responsive hydrogels are particularly interesting because their gelation and changes
in swelling can be triggered by temperature change [6–8]. In biomedical applications, this can be
accomplished through temperature increase from ambient to physiological. These systems allow
for in situ hydrogel formation, where a biomaterial can be delivered in solution in a minimally
invasive manner and solidify inside the body. Hydrogel formation for many systems happens almost
instantaneously once the gelation temperature is reached [9,10].
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Stimuli-responsive hydrogels can be loaded with drugs, cells, and growth factors and control
their release by changing the gel structure in response to application of the external stimuli [11].
Many physical and chemical stimuli have been applied to induce various responses of the smart
hydrogel systems. The physical stimuli include temperature, electric and magnetic fields, light, and
pressure, while the main chemical stimuli include pH [2,12]. Smart hydrogels have been used in diverse
applications, such as in making artificial muscles [13,14], chemical valves [15], and self-regulated drug
delivery systems [16–18].
Hydrogels have been used in injectable system which will result in a minimal invasive surgical
procedure with decreased patient morbidity, a lower risk of infection and the ability to fill irregular
shaped defects avoiding the need for patient specific prefabrication [19–21].
Pluronics (PEOx-PPOy-PEOx) are non-ionic triblock copolymers composed of two hydrophilic
side chains of poly (ethylene oxide), PEO, and a central hydrophobic chain of poly (propylene oxide),
PPO. They are also known as poloxamers and are non-toxic, biodegradable and FDA approved [22].
There are an extensive variety of Pluronics in the market named by its molecular weight and the
ratio between hydrophobic and hydrophilic units. They have many applications in different fields
such as cosmetics, pharmaceuticals and food emulsions [23–26] due to their self-assembly properties,
interfacial properties and their ability to form thermoreversible micelles and gels [27–29].
Pluronic F127® is one of the most used in regenerative medicine. One of its main characteristics is
that it forms a gel at relatively low concentrations and temperatures close to room temperature [30,31],
which is very interesting for biomedical applications. In addition, it is widely used due to its
simple phase diagram with water compared to other Pluronics [31]. Because of these features, the
binary systems Pluronic F127/water have been used in clinical applications such as drug and gene
delivery [32] and cell separation [33].
In this paper we report the effect of the addition of alginate microparticles to the Pluronic
F127/water system, in the rheological behavior of the composites, in view of its application as injectable
hydrogel that may present two different rates of drug release, one from the gel itself and another one
from the added microparticles. In addition, the kinetics of drug release in the hydrogel, and in the
alginate microparticles/Pluronic hydrogel composites was also determined.
2. Experimental
2.1. Materials and Sample Preparation
The triblock copolymer Pluronic®F127 (Sigma-Aldrich, Darmstadt, Germany) was used as
received. The aqueous solutions of F127 were prepared by cold method: required amounts of
deionized water and copolymer was weighted and mixed in a vial, sealed and kept in a refrigerator
until a homogeneous solution was formed (typically 1 or 2 days). Solutions of different Pluronic
concentrations, 12.5, 15, 15.5, 17.5, 20, and 22.5 wt%, were prepared. For the preparation of the
microparticles a 1 wt% aqueous solution of Na-alginate was used (Alginic Acid Sodium Salt, Panreac
AppliChem, Darmstadt, Germany). The solution was extruded dropwise into a 5 wt% CaCl2 aqueous
solution. Upon contact with the crosslinking solution (CaCl2) almost spherical-shaped particles
instantaneously formed and could harden overnight. The size was controlled by regulating the flow
rate using a syringe pump (KDS) and by applying a coaxial air stream (Encapsulation Unit Nisco,
Zurich, Switzerland, model Var J1). After completion of the gelling period the microspheres were
recovered, rinsed with water to remove CaCl2 in excess and dried overnight in a vacuum oven at 30 ◦C.
For a selected concentration of Pluronic/water system, different amounts of alginate microparticles
were added: 5, 10, and 15 wt%. Methylene blue (MB, high purity, Alfa Aesar, Karlsruhe, Germany)
was selected as a water-soluble model drug. Blank alginate microparticles (572 mg) were suspended in
30 mL of MB solution (25 mM). The suspension was stirred for 24 h at room temperature and then
lyophilized. MB-loaded microparticles were then dried and stored in a desiccator for further evaluation.
Materials 2019, 12, 1083 3 of 13
2.2. Particle Size Distribution
The Sauter diameter (D[3,2]) and volumetric mean diameter (D[4,3]) of the alginate microparticles
was determined by Laser Diffraction in a Mastersizer 2000 (Malvern, Worcestershire, UK). To do so, a
small portion of alginate microparticles was suspended in water before loading into the apparatus.
2.3. Rheological Characterization
The rheological characterization was performed in an AR2000 rotational rheometer (TA
Instruments, New Castle, DE, USA), using a plate/plate geometry (60 mm diameter) and a gap
of 1 mm in case of Pluronic/water system and 2 mm in case of the composites. A solvent trap was
used to prevent water evaporation. Steady state and oscillatory shear measurements were performed
at different temperatures and in function of temperature. The measurements were made in triplicate.
2.4. Drug Release
In vitro release assays were performed using a home-made membrane diffusion system with
a permeation area around 3.14 cm2, with artificial membranes acting as a barrier. First, a solution
with 25 mM of MB in Pluronic and a composite system consisting of a suspension of microparticles
loaded with MB in Pluronic (10% (wt/v) in Pluronic) were prepared. The donor compartment was
filled with 5 mL of Pluronic/MB solution or 5 mL of Pluronic/MB-loaded microparticles. The receptor
compartment was filled with 55 mL of PBS (Phosphate Buffer Saline) solution. After filling the diffusion
system was kept at 37 ◦C. Aliquots from the receptor compartment (at regular periods of time intervals
for both assays) were withdrawn (30 mL) and analyzed by UV-vis spectrophotometry (T90+ UV/VIS
Spectrometer, PG Instruments Ltd., Leicestershire, UK). The amount withdrawal was replaced with
fresh PBS. The measurements were made in triplicate.
3. Results and Discussion
3.1. Particle size distribution (PSD)
The particles present a monomodal distribution with the peak centered at about 417 µm. The mean
particle diameter is expressed as Sauter diameter (D[3,2]) and volumetric mean diameter (D[4,3]),
given by Equation (1).
D[M, N] =
[∫
DM n(D)dD∫
DN n(D)dD
] 1
M−N
(1)
The results obtained were: D[3,2] = 379 µm; D[4,3] = 401 µm.
3.2. Rheological Characterization
3.2.1. Pluronic/Water Systems
Pluronic F127, like other Pluronics, are amphiphilic polymers that undergo micellization in
water, through the hydrophobic self-aggregation, when a critical micellization concentration (CMC),
at room temperature, or a critical micellization temperature, for a certain concentration, are reached.
The assembling of micelles, due to the decrease of intermicellar distance, forms a gel network, through
entanglements, at a critical temperature, the gelation temperature. Two mechanisms were proposed
for the decrease of intermicellar distance [34]. In the first one, the micellar sizes remain the same but
new micelles are formed during heating, approaching each other, while in the second one, the number
of micelles remains unchanged but their size is increased with temperature, which also brings them
closer to each other.
Figure 1a presents the sol-gel transition followed by oscillatory shear measurements for two
Pluronic concentrations, while Figure 1b shows the gelation temperature (Tgel) for all the concentrations
studied, except for the less concentrated ones (below 15.5 wt%) that did not show any gelation. Tgel
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was determined from the crossover between G′ and G′ ′. For sake of clarity only G′ is presented in
Figure 2. As can be seen, at the sol-gel transition the standard deviations are high, however, the
determined values of Tgel are accurate since their standard deviations are small (Figure 1b). Similar
gelation temperatures were already determined [35,36].
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gelation temp rature decreases linearly with copolymer conc tration as shown in Figure 2.
This is a common finding, for either Pluronic F127 [35,36] or for other Plur nics [34,37].
Figure 3a shows the results of the frequency dependence of elastic (G′) modulus, in the LVR, at
37 ◦C (body temperature) for selected concentrations, and the viscosity curves at 18 and 20 ◦C (around
surgery room temperature) are presented in Figure 3b, for the same concentrations. Figure 3a shows
that the elastic modulus is almost independent of the angular frequency, a characteristic of the gel state.
The same behavior was already reported [38]. It also shows that the elastic modulus increases with
concentration of Pluronic at 37 ◦C (gel state), as expected, and also found by Zhao et al. [39].
Figure 3b shows that the apparent viscosities at relatively low temperatures (sol state) increase
with polymer concentration, as expected in a polymer solution. An increase of viscosity is also observed
when increasing the temperature from 18 to 20 ◦C, which is due to the closest approximation to Tgel
and the decrease of the intermicellar distance.
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smallest apparent viscosity during the injection process. The 15.5 wt% system fulfills two of those
requirements, and its G’ values at 37 °C, despite being the smallest ones, are high enough to keep it 
in place in body cavity, so, this concentration was chosen for basis of the composite system.
3.2.2. Pluronic/Water System Filled with Alginate Microparticles 
Figure 3. G′ as a function of angular frequency at 37 ◦C (a) and viscosity curves at 18 and 20 ◦C (b) for
selected Pluronic concentrations. Values are represented as mean ± standard deviation (n = 3).
Considering the intended application, the optimal system would be the one presenting a Tgel
as closest as body temperature as possible, the highest elastic modulus at body temperature and the
smallest apparent viscosity during the injection process. The 15.5 wt% system fulfills two of those
requirements, and its G′ values at 37 ◦C, despite being the smallest ones, are high enough to keep it in
place in body cavity, so, this concentration was chosen for basis of the composite system.
3.2.2. Plur nic/Water System Filled wi h Alginate Microparticles
Figure 4a presents the sol-gel transition followed by oscillatory shear measurements for two
different contents of alginate microparticles, as examples, while Figure 4b shows the dependence of
the sol-gel transition temperature (Tgel) with the content of alginate microparticles. As observed, the
higher the alginate microparticles content, the smallest Tgel. This decrease in Tgel may be explained by
hydrogen bonds between the carboxyl groups of alginate and ether groups of Pluronic, which may
lead to the formation of a three-dimensional network at temperatures below the ones at which the
micelles of Pluronic F127 entangle to form the gel [40].
Once again, despite the fact that, at the sol-gel transition, the standard deviations are high
(especially for 5 wt% alginate microparticles content, as shown in Figure 3a), the determined values of
Tgel are accurate since their standard deviations are small (Figure 3b).
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15.5 wt% Pluronic/water system (a) and gelation temperature as a function of alginate icroparticles
content (b). alues are represented as ean standard deviation (n = 3).
Figure 5 shows the results of t e frequency dependence f elastic (G′) modulus at 37 ◦C (body
t mper ture) for different contents of alginate microparticles, a d Figure 5b pres nts the viscosity
curv s at 18 and 20 ◦C (around surgery room temperature) for th same composites. Note that the
15 wt% alginate microparticles results are not presented since the gelation temperature is already too
low for the intended application. In fact, being the gelation temperature just slightly higher than the
temperature of the injected solution, it will immediately jellify when entering the body, not leaving
time for the complete injection.
Materials 2019, 12, 1083 8 of 13
Materials 2019, 10, x FOR PEER REVIEW  8 of 14 
 
Figure 5a shows the results of the frequency dependence of elastic (G’) modulus at 37 °C (body 
temperature) for different contents of alginate microparticles, and Figure 5b presents the viscosity 
curves at 18 and 20 °C (around surgery room temperature) for the same composites. Note that the 15 
wt% alginate microparticles results are not presented since the gelation temperature is already too 
low for the intended application. In fact, being the gelation temperature just slightly higher than the 
temperature of the injected solution, it will immediately jellify when entering the body, not leaving 
time for the complete injection 
As seen in Figure 5a, the elastic modulus is almost independent of alginate microparticles 
content, the differences lying within the experimental error. This result shows that the elastic 
behavior is dictated by the micellar structure of Pluronic F127. On the other side, the increase of the 
alginate microparticles content increases the shear apparent viscosity (Figure 5b), as expected when 
microparticles are added to a viscous continuum phase, and, once again, an increase in temperature 
leads to higher viscosity, due to the decrease of intermicellar distance with temperature. 
 
(a) 
Materials 2019, 10, x FOR PEER REVIEW  9 of 14 
 
 
(b) 
Figure 5. G’ as a function of angular frequency (a) and viscosity curves (b) for different contents of 
alginate microparticles in a 15.5 wt% Pluronic/water system. Values are represented as mean ± 
standard deviation (n = 3). 
To study the time available for the injection, time sweep tests were performed. The solution was 
kept at 15 °C before the measurement took place, and then the viscoelastic modulus was measured 
with a set temperature of 37 °C. The time elapsed between the start of the measurements and the 
moment a crossover between G’ and G’’ took place (which was obviously due to the increase in 
temperature during the measurements) was considered the time available for the injection. Figure 6 
presents the results obtained for 5 and 10 wt% alginate microparticles content, the ones of interest, as 
concluded from previous results. 
 
Figure 6. G’ and G’’ (f = 1 Hz) as a function of time after a sudden increase in temperature from 15 to 
37 °C for 5 and 10 wt% alginate microparticles content in a 15.5 wt% Pluronic/water system. The 
Figure 5. G′ as a function of angular frequency (a) and viscosity curves (b) or different contents
of alginate microparticles in a 15.5 wt% Pluronic/water system. Values are presented as mean ±
stan ard deviation (n = 3).
As seen in Figure 5a, th elastic modulus is almost independent of alginat microparticles content,
the differenc s lying within th experimental error. This result shows that the elastic beh vior is dictated
by th micellar s ructure of Pluronic F127. On the other side, the increase of th alginat microparticles
content increases the sh ar apparent visc sity (Figure 5b), as expected when micr particles are added
to a viscous co tinuu phas , and, once again, an incr ase in temperature leads to higher viscosity,
due to the decrease of intermicellar distance with t pe atu e.
To study th time available for the injection, time sweep tests were performed. The solution was
kept at 15 ◦C before the measurement took place, and then the viscoelastic modulus was measured
Materials 2019, 12, 1083 9 of 13
with a set temperature of 37 ◦C. The time elapsed between the start of the measurements and the
moment a crossover between G′ and G′ ′ took place (which was obviously due to the increase in
temperature during the measurements) was considered the time available for the injection. Figure 6
presents the results obtained for 5 and 10 wt% alginate microparticles content, the ones of interest, as
concluded from previous results.
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The analysis of Figure 6 allows for the determination of the limiting time for the injection
procedure, the time at which G′ increases abruptly. The increase of alginate microparticles content
from 5 to 10 wt%, decreases the limiting time from around 80 s to a little less than 40 s. The maximum
content of alginate microparticles will then be conditioned by the size and location of injury, that will
dictate the time needed for the injection procedure.
3.3. Drug Release
Figure 7 shows the release profiles of 15.5 wt% Pluronic hydrogel/10 % (wt/v) MB-loaded
microparticles (composite) and 15.5 wt% Pluronic hydrogel/MB systems at body temperature. It can
be observed that in the composite system MB has a much slower release. After 24 h MB was completely
released from the 15.5 wt% Pluronic aqueous solution/MB system while for the composite system
only 38.2% of MB was released in the same period and complete release of MB only happened after
240 h. This delayed release obtained for the composite system is due to different release kinetics of
MB from the microspheres and from the Pluronic hydrogel. Drug release experiments here presented
suggest that 15.5 wt% Pluronic hydrogel/10% (wt/v) MB-loaded microspheres can be used in dual
drug release systems. Release experiments using different drugs in the alginate microspheres and
in the Pluronic hydrogel must be performed to further characterize these dual systems. Combined
therapy with drugs of different therapeutic effects using Dual Drug Delivery Systems (DDDS) is
an effective way to control the release behavior of each drug independently. Combined delivery of
anticancer drugs with different mechanisms of action allows overcoming undesirable toxicity and
other side effects and to circumvent multidrug resistance [41]. Many DDDS reported in the literature
are based on hydrogel/polymeric micelle composites [41–44]. These dual systems have also been used
for controlled delivery in hard tissue engineering [45,46], where different drugs or a combination of
drugs and cells or growth factors were used.
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the injection procedure from around 80 s to a little less than 40 s. The maximum content of alginate 
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In order to perform drug release studies 10% (wt/v) alginate microparticles addition, relative to 
the weight of hydrogel, was chosen. Drug release results showed that the incorporation of MB-loaded 
alginate microparticles in 15.5 wt% Pluronic hydrogel delayed 10 times the release of MB, when 
compared with MB/Pluronic hydrogel system alone, demonstrating its potential in the development 
of dual release systems either for drug delivery or tissue engineering. Other release studies using 
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Figure 7. Release profiles of Methylene Blue in PBS for Pluronic/MB and Pluronic/MB-loaded
microspheres systems. Values are represented as mean ± standard deviation (n = 3).
Fitting of the drug release data was performed using a freely available add-in program called
DDSolver, developed by Zhang et al. [47]. The best model was chosen considering the one with the
highest adjusted coefficient of determination, which can be det mined by Equation (2) [48]:
R2adj = 1−
n− 1
n− p
(
1− R2
)
(2)
For both systems the Korsmeyer–Peppas model was the one that best fitted the MB release data,
presenting a R2adj value of 0.98.
Korsmeyer–Peppas model is described by Equation (3):
Qt = ktn (3)
where Q is the fraction of drug released at time t and k is the release rate. The expo ent n gives
info mation about the release mechanism. If n ≤ 0.43 it is a Fickian diffusion and if n = 0.85 it is a case
II transport, b ing related to polymer matrix relaxation and swelling. If 0.43 < n < 0.85 it corresponds
to an an malous transport, resultant form the combination of both echanisms. A special case, when
n > 0.85, corresponds to a super case II transport. For the 15.5 wt% Pluronic aqueous solution/MB, a
value of n = 1.00 was obtained, corresponding to a super case II transport mechanism. In this case, the
release mechanism is dependent on the relaxation of th p lymeric chains. For the composite syst m
the value of n was approximately 0.46. This value is close to th 0.43 limit, which means that the
releas mechanism is predomina tly related to th Fickian diffusion f MB rou h th system [48,49].
In the composite systems the MB is firstly r leased from the microspheres i to the Pluronic hydrog l
and af erwards will diffuse rough it. Total r lease of MB from the alginate microspheres c n only
be observed af er their c mplete swelling/dissolution and, for thi reason, an extended release is
observed in the composite system (see Figure 6).
4. Conclusions
Th Pluronic F127®/water system with different polym r concentrations were characte ized
rheologically, showing that 15.5 wt% polymer concentration is an adequate concentrati n for use as
injectable gel. The effect of the addition of different amounts of alginate microparticles to the 15.5 wt%
Pluronic/water system in the rheological behavior was analyzed.
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The results obtained showed that the addition of the microparticles are not determinant in the
value of the elastic modulus at body temperature, however, it increases the viscosity of the solutions
and decreases the gelation temperature, which limits the percentage of microparticles to be added.
The time that takes, after a sudden increase in temperature from 15 to 37 ◦C, for the gelation to occur,
also depends on the concentration of alginate microparticles, decreasing with its increase. In fact, the
increase of alginate microparticles content from 5 to 10 wt%, decreases the limiting time available for
the injection procedure from around 80 s to a little less than 40 s. The maximum content of alginate
microparticles will then be conditioned by the size and location of injury, that will dictate the time
needed for the procedure.
In order to perform drug release studies 10% (wt/v) alginate microparticles addition, relative to
the weight of hydrogel, was chosen. Drug release results showed that the incorporation of MB-loaded
alginate microparticles in 15.5 wt% Pluronic hydrogel delayed 10 times the release of MB, when
compared with MB/Pluronic hydrogel system alone, demonstrating its potential in the development
of dual release systems either for drug delivery or tissue engineering. Other release studies using
different drugs (or a combination of drugs and cells or growth factors) in the alginate microparticles
and in the Pluronic hydrogel must be performed considering the intended application Further stability
studies regarding the integrity of these dual systems must be performed, which are also dependent on
the drugs or drug/cell/growth factors combinations used in their production.
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